Skip to main content
Livermore
Livermore
ZHEN

Diadema Partners LP

SEC CIK
0002026172
Latest filing
Aug 14, 2026

Holdings in Q2 2026

Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.

Institution overview
Positions
78
−8 vs. Q1 2026
Portfolio value
$283.2M
+$41.0M (+16.9%) vs. Q1 2026
Filed
Aug 14, 2026
SEC
Holdings of Diadema Partners LP in Q2 2026
SecurityClassSharesValue% of portfolioShare changeActionHistory
UTHRUnited Therapeutics CorpCOM52,989$28.7M10.1%+25,686+94.1%AddedHistory
RVMDRevolution Medicines, Inc.COM139,218$26.1M9.2%+58,346+72.1%AddedHistory
ABVXAbivax S.A.SPONSORED ADS163,644$21.6M7.6%+87,700+115.5%AddedHistory
COGTCogent Biosciences, Inc.COM493,664$19.1M6.7%+170,900+52.9%AddedHistory
BridgeBio Pharma, Inc.10806XAJ1NOTE 1.750% 3/0–$18.6M6.6%–––
BMRNBiomarin Pharmaceutical IncCOM312,846$17.9M6.3%+164,617+111.1%AddedHistory
VKTXViking Therapeutics, Inc.COM441,808$17.2M6.1%−83,373−15.9%ReducedHistory
EWTXEdgewise Therapeutics, Inc.COM272,214$11.1M3.9%+272,214NewHistory
KODKodiak Sciences Inc.COM218,117$8.50M3.0%+25,155+13.0%AddedHistory
IMCRImmunocore Holdings plcADS254,863$8.09M2.9%+61,674+31.9%AddedHistory
FDMT4D Molecular Therapeutics, Inc.COM571,107$7.60M2.7%+571,107NewHistory
RCUSArcus Biosciences, Inc.COM223,810$6.90M2.4%−14,332−6.0%ReducedHistory
JNJJohnson & JohnsonStock22,000$5.59M2.0%−31,771−59.1%ReducedHistory
NVONovo Nordisk A SADR100,000$4.81M1.7%+85,423+586.0%AddedHistory
CRVSCorvus Pharmaceuticals, Inc.COM294,811$4.40M1.6%+50,000+20.4%AddedHistory
RLAYRelay Therapeutics, Inc.COM230,677$4.32M1.5%+230,677NewHistory
ZYMEZymeworks Inc.COM142,132$3.72M1.3%00.0%UnchangedHistory
BIOABioAge Labs, Inc.COM146,334$3.59M1.3%+86,334+143.9%AddedHistory
TSHATaysha Gene Therapies, Inc.COM SHS522,619$3.56M1.3%+522,619NewHistory
NRIXNurix Therapeutics, Inc.COM121,539$2.95M1.0%+121,539NewHistory
CRBPCorbus Pharmaceuticals Holdings, Inc.COM NEW301,264$2.83M1.0%−138,693−31.5%ReducedHistory
INDVIndivior Pharmaceuticals, Inc.COM67,512$2.77M1.0%−3,864−5.4%ReducedHistory
IVAInventiva S.A.ADS740,786$2.73M1.0%+388,387+110.2%AddedHistory
ORKAOruka Therapeutics, Inc.COM27,799$2.65M0.9%+27,799NewHistory
PCVXVaxcyte, Inc.COM45,071$2.62M0.9%+20,000+79.8%AddedHistory
RLMDRelmada Therapeutics, Inc.COM361,367$2.50M0.9%+160,525+79.9%AddedHistory
VERAVera Therapeutics, Inc.CL A57,608$2.47M0.9%+57,608NewHistory
CTNMContineum Therapeutics, Inc.CL A119,733$1.96M0.7%+119,733NewHistory
BCYCBicycle Therapeutics PLCSPONSORED ADS462,724$1.96M0.7%−13,700−2.9%ReducedHistory
GLUEMonte Rosa Therapeutics, Inc.COM78,391$1.90M0.7%−108,916−58.1%ReducedHistory
VRDNViridian Therapeutics, Inc.COM100,000$1.84M0.6%+100,000NewHistory
MGNXMacrogenics IncCOM374,403$1.73M0.6%−225,597−37.6%ReducedHistory
PRQRProQR Therapeutics N.V.SHS EURO926,016$1.72M0.6%+745,933+414.2%AddedHistory
SPRBSpruce Biosciences, Inc.COM NEW30,000$1.62M0.6%+20,000+200.0%AddedHistory
ARDXArdelyx, Inc.COM303,025$1.55M0.5%+303,025NewHistory
CUECue Biopharma, Inc.COM48,369$1.53M0.5%+48,369NewHistory
MLYSMineralys Therapeutics, Inc.COM56,347$1.52M0.5%+30,000+113.9%AddedHistory
PRTAProthena Corp Public Ltd CoSHS149,482$1.46M0.5%+149,482NewHistory
VYGRVoyager Therapeutics, Inc.COM413,642$1.45M0.5%−10,000−2.4%ReducedHistory
UNCYUnicycive Therapeutics, Inc.COM NEW303,676$1.42M0.5%+197,593+186.3%AddedHistory
PHATPhathom Pharmaceuticals, Inc.COM129,950$1.41M0.5%+75,300+137.8%AddedHistory
SYRESpyre Therapeutics, Inc.COM NEW15,000$1.33M0.5%+15,000NewHistory
HELPHelus Pharma Inc.COM NEW200,000$1.32M0.5%+200,000NewHistory
EQEquillium, Inc.COM400,282$1.28M0.5%−33,562−7.7%ReducedHistory
XERSXeris Biopharma Holdings, Inc.COM132,746$1.05M0.4%00.0%UnchangedHistory
PHVSPharvaris N.V.COM29,321$1.01M0.4%00.0%UnchangedHistory
HRMYHarmony Biosciences Holdings, Inc.COM26,864$978.1K0.3%−66,000−71.1%ReducedHistory
RNACCartesian Therapeutics, Inc.COM NEW87,057$907.1K0.3%+87,057NewHistory
RIGLRigel Pharmaceuticals IncCOM22,816$892.6K0.3%+22,816NewHistory
SMMTSummit Therapeutics Inc.COM60,000$874.2K0.3%+60,000NewHistory
PGENPrecigen, Inc.COM135,293$771.2K0.3%+80,000+144.7%AddedHistory
DFTXDefinium Therapeutics, Inc.COM SHS15,451$726.8K0.3%+15,451NewHistory
PTHSPelthos Therapeutics Inc.COM SHS24,773$700.1K0.2%00.0%UnchangedHistory
PEPGPepGen Inc.COM373,284$671.9K0.2%+222,359+147.3%AddedHistory
ELVNEnliven Therapeutics, Inc.COM10,000$507.5K0.2%+9,755+3,981.6%AddedHistory
CNTBConnect Biopharma Holdings LtdSHS196,985$468.8K0.2%−3,705−1.8%ReducedHistory
LRMRLarimar Therapeutics, Inc.COM146,637$447.2K0.2%−20,000−12.0%ReducedHistory
CLRBCellectar Biosciences, Inc.COM NEW138,341$384.6K0.1%+138,341NewHistory
FHTXFoghorn Therapeutics Inc.COM66,908$326.5K0.1%−13,036−16.3%ReducedHistory
AYTUAytu Biopharma, IncCOM148,546$319.4K0.1%−204,531−57.9%ReducedHistory
OCGNOcugen, Inc.COM200,000$306.0K0.1%00.0%UnchangedHistory
URGNUroGen Pharma Ltd.COM7,137$262.6K0.1%−16,018−69.2%ReducedHistory
AMGNAmgen IncStock102,701$214.6K0.1%+102,701NewHistory
HRTXHeron Therapeutics, Inc.COM458,723$195.8K0.1%+458,723NewHistory
TLPHTalphera, Inc.COM NEW153,563$158.2K0.1%00.0%UnchangedHistory
ANNXAnnexon, Inc.COM27,516$157.1K0.1%−105,400−79.3%ReducedHistory
MNPRMonopar TherapeuticsCOM NEW1,630$150.9K0.1%00.0%UnchangedHistory
LAKELakeland Industries IncCOM14,108$150.8K0.1%+14,108NewHistory
UPBUpstream Bio, Inc.COM19,093$132.1K<0.1%−2,516−11.6%ReducedHistory
MGTXMeiraGTx Holdings plcCOM8,368$113.1K<0.1%+8,368NewHistory
JATTJATT II Acquisition Corp.ORD SHS9,021$102.5K<0.1%+9,021NewHistory
KLRAKailera Therapeutics, Inc.COMMON STOCK3,621$79.8K<0.1%+3,621NewHistory
MNKDMannkind CorpCOM NEW16,003$68.2K<0.1%−170,600−91.4%ReducedHistory
ENTXEntera Bio Ltd.SHS23,260$41.2K<0.1%00.0%UnchangedHistory
SPRYARS Pharmaceuticals, Inc.COM4,860$38.9K<0.1%+4,860NewHistory
APREAprea Therapeutics, Inc.COM NEW44,907$36.0K<0.1%+44,907NewHistory
TVRDTvardi Therapeutics, Inc.COM16,607$31.6K<0.1%+16,607NewHistory
NXTCNextCure, Inc.COM NEW7,742$12.4K<0.1%+7,742NewHistory

Options (57)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Diadema Partners LP in Q2 2026
SecurityClassPutsCalls
ABVXAbivax S.A.SPONSORED ADS$33.6M$46.5M
VKTXViking Therapeutics, Inc.COM$13.7M$47.6M
BMYBristol Myers Squibb CoStock$19.0M$34.6M
QUREuniQure N.V.SHS$13.8M$10.8M
NVSNovartis AGADR$15.7M$7.84M
CAPRCapricor Therapeutics, Inc.COM NEW$12.9M$7.93M
CORTCorcept Therapeutics IncCOM–$17.9M
KYMRKymera Therapeutics, Inc.COM–$17.2M
SMMTSummit Therapeutics Inc.COM$2.91M$12.5M
HIMSHims & Hers Health, Inc.Stock$6.72M$6.93M
KODKodiak Sciences Inc.COM$5.72M$7.66M
REPLReplimune Group, Inc.COM$5.56M$7.71M
BIIBBiogen Inc.COM–$13.0M
LLYEli Lilly & CoStock$12.0M–
INCYIncyte CorpCOM$11.9M–
BNTXBioNTech SESPONSORED ADS–$9.30M
SLSSELLAS Life Sciences Group, Inc.COM NEW$1.48M$5.90M
MRNAModerna, Inc.Stock$7.00M–
CRBPCorbus Pharmaceuticals Holdings, Inc.COM NEW–$5.95M
PCVXVaxcyte, Inc.COM$2.84M$3.09M
ALMSAlumis Inc.COM–$5.63M
RPRXRoyalty Pharma plcSHS CLASS A–$5.61M
CLDXCelldex Therapeutics, Inc.COM NEW$3.20M$1.89M
BIOABioAge Labs, Inc.COM–$4.90M
BHVNBiohaven Ltd.COM–$4.72M
TENXTenax Therapeutics, Inc.COM NEW–$4.47M
TGTXTG Therapeutics, Inc.COM–$4.16M
GLUEMonte Rosa Therapeutics, Inc.COM–$4.12M
RCUSArcus Biosciences, Inc.COM–$3.82M
UNCYUnicycive Therapeutics, Inc.COM NEW–$3.72M
AMGNAmgen IncStock–$3.62M
NTLAIntellia Therapeutics, Inc.COM–$3.38M
NVONovo Nordisk A SADR$2.68M–
CYTKCytokinetics IncCOM NEW$2.56M–
VERAVera Therapeutics, Inc.CL A$2.15M–
CELCCelcuity Inc.COM–$2.09M
ANNXAnnexon, Inc.COM–$2.02M
SEPNSepterna, Inc.COM$2.00M–
CRVSCorvus Pharmaceuticals, Inc.COM–$1.99M
ADMAAdma Biologics, Inc.COM–$1.67M
EYPTEyePoint, Inc.COM NEW–$1.52M
EOLSEvolus, Inc.COM–$1.39M
CRMDCorMedix Inc.COM$1.31M–
EDITEditas Medicine, Inc.COM–$1.30M
PYXSPyxis Oncology, Inc.COMMON STOCK–$1.17M
AQSTAquestive Therapeutics, Inc.COM–$892.7K
ELTXElicio Therapeutics, Inc.COM$391.0K$438.3K
HELPHelus Pharma Inc.COM NEW–$661.0K
VYGRVoyager Therapeutics, Inc.COM–$525.0K
CGONCG Oncology, Inc.COM–$518.7K
INOInovio Pharmaceuticals, Inc.COM SHS–$302.7K
VTGNVistagen Therapeutics, Inc.COM–$13.0K
ATYRaTYR PHARMA INCCOM NEW$7.46K–
MGTXMeiraGTx Holdings plcCOM–$6.75K
JBIOJade Biosciences, Inc.COM NEW$3.17K–
ERASErasca, Inc.COM–$1.83K
CUECue Biopharma, Inc.COM–$6

Sold out since Q1 2026 (37)

Positions held at the end of Q1 2026 that are gone from this filing.

Positions of Diadema Partners LP sold out since Q1 2026
SecurityClassShares in Q1 2026Value in Q1 2026% of portfolio in Q1 2026History
JAZZJazz Pharmaceuticals plcSHS USD54,755$10.4M4.3%History
TERNTerns Pharmaceuticals, Inc.COM181,752$9.58M4.0%History
INCYIncyte CorpCOM78,029$7.34M3.0%History
TGTXTG Therapeutics, Inc.COM206,928$6.87M2.8%History
BBIOBridgeBio Pharma, Inc.COM85,311$6.34M2.6%History
LLYEli Lilly & CoStock6,000$5.52M2.3%History
ABBVAbbVie Inc.Stock24,058$5.23M2.2%History
GPCRStructure Therapeutics Inc.SPONSORED ADS72,234$3.48M1.4%History
TENXTenax Therapeutics, Inc.COM NEW179,738$2.87M1.2%History
CAPRCapricor Therapeutics, Inc.COM NEW78,851$2.40M1.0%History
EYPTEyePoint, Inc.COM NEW178,545$2.30M1.0%History
CLYMClimb Bio, Inc.COM286,126$1.96M0.8%History
STTKShattuck Labs, Inc.COM293,664$1.89M0.8%History
TARSTarsus Pharmaceuticals, Inc.COM25,942$1.82M0.8%History
ALKSAlkermes plc.SHS50,000$1.77M0.7%History
VRTXVertex Pharmaceuticals IncStock3,840$1.71M0.7%History
INOInovio Pharmaceuticals, Inc.COM SHS562,665$979.0K0.4%History
DNTHDianthus Therapeutics, Inc.COM10,000$839.2K0.3%History
ENTAEnanta Pharmaceuticals IncCOM64,952$820.3K0.3%History
REPLReplimune Group, Inc.COM100,660$770.0K0.3%History
RAREUltragenyx Pharmaceutical Inc.COM35,144$736.3K0.3%History
CELCCelcuity Inc.COM5,314$606.5K0.3%History
QUREuniQure N.V.SHS31,200$510.1K0.2%History
MAZEMaze Therapeutics, Inc.COM15,000$447.8K0.2%History
CORTCorcept Therapeutics IncCOM10,000$403.1K0.2%History
LPCNLipocine Inc.COM NEW50,000$399.5K0.2%History
GHRSGH Research PLCORDINARY SHARES26,836$377.3K0.2%History
EPRXEupraxia Pharmaceuticals Inc.COM40,000$289.6K0.1%History
TRVITrevi Therapeutics, Inc.COM21,663$258.4K0.1%History
CMPSCOMPASS Pathways plcSPONSORED ADS31,885$176.3K0.1%History
PASGPassage BIO, Inc.COM19,530$153.3K0.1%History
RCKTRocket Pharmaceuticals, Inc.COM30,579$109.5K<0.1%History
VTGNVistagen Therapeutics, Inc.COM105,428$60.3K<0.1%History
RNAAtrium Therapeutics, Inc.COM2,512$33.6K<0.1%History
CUECue Biopharma, Inc.COM131,997$30.3K<0.1%History
PRTCYPureTech Health plcADS7,924$11.3K<0.1%History
SEPNSepterna, Inc.COM202$4.85K<0.1%History